Celaxis Bioscience Private Limited - Due diligence report

A 360° intelligence report on Celaxis Bioscience Private Limited: trust score, financial health, credit view, compliance, directors, growth …

2020-08-23 Himatnagar, Gujarat Active Unlisted
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Celaxis Bioscience Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
89/100
Trust Score
Low Risk

Celaxis Bioscience Private Limited is assessed as Low Risk with a Trust Score of 89/100. Celaxis Bioscience Private Limited is an active private limited indian non-government company incorporated in 2020, operating in the Pharma sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 27 Oct 2026 from the latest processed filings. Celaxis Bioscience Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
89/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 2 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 55/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Moderate gearing (D/E 38%).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 2 open (19.00 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Others2 48.0 cr
Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
RAMESH KALAWADIA MAKANBHAI 01234567 Director 01/04/2018 6 yrs Approved
CHETAN SATYENDRA MAJMUDAR 01234567 Director 01/04/2018 6 yrs Approved
JEVIL DINESHBHAI PATEL 01234567 Director 01/04/2018 6 yrs Approved
DARSHAN MAHENDRA MAHENDRA 01234567 Director 01/04/2018 6 yrs Approved
DINESHKUMAR AMICHANDBHAI PATEL 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
06

Ownership & Group Intelligence

As per FY 2021 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
3 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 65 · Distress 90
Growth signals & trust indicators
Profit expanded 1.42 year-on-year.
Asset base grew 2.1x - capacity expansion.
Operating for 6 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
2 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence89/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment74/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 19.00 cr already registered.
  • Compliance record supports lending.
Investor view80/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 12 events
30 Sep 2025
Last AGM held
Annual general meeting
01 Jun 2025
Director appointed
RAMESH KALAWADIA MAKANBHAI (Director)
Director appointed
CHETAN SATYENDRA MAJMUDAR (Director)
31 Mar 2025
Latest balance sheet
Filed with ROC
08 Apr 2022
Securities allotted
1000000 Equity Shares Without Differential Rights - 1.00 cr raised
20 Dec 2021
Securities allotted
1300000 Equity Shares Without Differential Rights - 1.30 cr raised
15 Dec 2021
Charge created
Others - 9.50 cr
22 Jul 2021
Securities allotted
670000 Equity Shares Without Differential Rights - 67.00 Lakh raised
23 Aug 2020
Incorporated
Registered with Roc Ahmedabad
Director appointed
JEVIL DINESHBHAI PATEL (Director)
Director appointed
DARSHAN MAHENDRA MAHENDRA (Director)
Director appointed
DINESHKUMAR AMICHANDBHAI PATEL (Director)
10

Key Observations

Auto-generated from the data above
Debt-to-equity stands at 24% - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
5 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2021 annual return.
Capital has been raised through 3 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Sthree Pharmaceuticals Private Limited U24297TN2015PTC101802 Chennai, Tamil Nadu, India
Araneae Pharmaceutical Private Limited U24290UP2020PTC139707 Allahabad, Uttar Pradesh, India
Novelis Pharmaceuticals Private Limited U24100RJ2020PTC069258 Kota, Rajasthan, India
Larksois Pharma U24299MH2021PTC361202 Panvel, Maharashtra, India
Shree Krishnakanta Pharmaceuticals And Fine Chemicals Private Limited U24232PN2008PTC135131 Ratnagiri, Maharashtra, India
Pdg Pharmachem Private Limited U27310DL2005PTC132747 Na, Delhi, India
Sds Pharmaceuticals Private Limited U24232DL2014PTC264882 New Delhi, Delhi, India
Deific Life Sciences Private Limited U51909DL2017PTC315003 New Delhi, Delhi, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Celaxis Bioscience Private Limited before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Celaxis Bioscience Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 65/100, margin trends, ownership structure and peer set for Celaxis Bioscience Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 89/100, distress signals and MSME payment-delay disclosures - know whether Celaxis Bioscience Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Celaxis Bioscience Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Celaxis Bioscience Private Limited an active company?

Celaxis Bioscience Private Limited has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Celaxis Bioscience Private Limited financially healthy?

Celaxis Bioscience Private Limited has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.

Should I do business with Celaxis Bioscience Private Limited?

Its overall Trust Score is 89/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Celaxis Bioscience Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 5 active director(s) are on record.

Does Celaxis Bioscience Private Limited have loans or charges against its assets?

2 open charge(s) are registered against its assets.

Is Celaxis Bioscience Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Celaxis Bioscience Private Limited?

Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.